Innate Pharma
IPHA
#8590
Rank
NZ$0.26 B
Marketcap
$3.08
Share price
-1.14%
Change (1 day)
-30.73%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2022: -NZ$0.12 Billion

According to Innate Pharma 's latest financial reports the company's current earnings are NZ$53.18 Million. In 2022 the company made an earning of -NZ$0.12 Billion a decrease over its 2021 earnings that were of -NZ$91.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2022

Annual earnings

Year Earnings Change
2022-NZ$0.12 Billion20.74%
2021-NZ$91.2 Million4951.09%
2020-NZ$1.81 Million-111.57%
2019NZ$15.6 M183.46%
2018NZ$5.5 M-105.4%
2017-NZ$0.11 Billion-523.25%
2016NZ$24.1 M-285.64%
2015-NZ$12.99 Million-69.31%
2014-NZ$42.31 Million498.29%
2013-NZ$7.08 Million-5.62%
2012-NZ$7.5 Million-53.32%
2011-NZ$16.05 Million-50.1%
2010-NZ$32.17 Million-13.3%
2009-NZ$37.11 Million26.36%
2008-NZ$29.37 Million27.35%
2007-NZ$23.06 Million63.33%
2006-NZ$14.12 Million9.81%
2005-NZ$12.86 Million